Skip to main content

Managing T2DM and T2DM-Related Comorbidities: The Role of SGLT2 Inhibitors


A CME/MOC Activity

TO REGISTER:
Click here to complete your registration.


If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.

DATE AND TIME
Thursday, June 17, 2021
7:00 PM – 8:00 PM ET (6:00 - 7:00 PM CT/4:00 - 5:00 PM PT)

AGENDA
Welcome and Introduction
Efficacy and Safety of SGLT2 Inhibitors for Managing T2DM and Comorbidities
Evidence-based Guideline Recommendations for the Use of SGLT2 inhibitors
Collaborative Care to Optimize Outcomes in T2DM
Q&A Session and Activity Roundup

PROGRAM DESCRIPTION
Type 2 diabetes mellitus (T2DM) is associated with numerous comorbid conditions. T2DM increasing the risk for cardiovascular disease (CVD), heart failure (HF), chronic kidney disease, blindness, neuropathy, and amputations. Sodium-glucose cotransporter 2 inhibitors (SGLT2s) are a recent addition to the armamentarium for managing T2DM. In addition to controlling A1c, SGLT2s are effective in improving CVD outcomes, preventing hospitalization for HF, and reduced risk of progression of renal disease. They have a good adverse event and tolerability profile and are administered orally.

The program "Managing T2DM and T2DM-Related Comorbidities: The Role of SGLT2 Inhibitors" will inform clinicians about the role of STLT2s in optimizing the management of T2DM, including reducing the risk for CVD, HF, and renal disease. In addition, the program will review strategies to develop multidisciplinary management teams and crafting management plans that reflect the patient’s perspective to improve adherence to their T2DM treatment regimen.

STEERING COMMITTEE
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Abington, PA

John J. Russell, MD, FAAFP
Chair, Department of Family Medicine
Director, Family Medicine Residency Program
Abington Memorial Hospital
Clinical Professor of Family and Community Medicine
Sidney Kimmel Medical College
Philadelphia, PA

TARGET AUDIENCE

This activity is intended for primary care physicians, who are clinicians responsible for the management of patients with type 2 diabetes mellitus.

EDUCATIONAL OBJECTIVES
At the conclusion of this education, participants should be able to:

  • Assess current efficacy and safety data for SGLT2 inhibitors for the management of T2DM as well as effects on comorbid conditions
  • Integrate current guideline recommendations for the use of SGLT2 inhibitors into individualize management plans for patients with T2DM
  • Employ strategies for effective collaborative management of T2DM in the setting of a multidisciplinary team
  • Engage in shared decision making with patients with T2DM to ensure adherence and optimize outcomes
PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION STATEMENT
Boston University School of Medicine designates this live virtual activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC RECOGNITION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through BUSM’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

DISCLAIMER
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKE IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

DISCLOSURE STATEMENT
This educational activity has been produced in adherence with the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Disclosures will be made known to the participants prior to the start of the activity.

FDA DISCLOSURE
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

SYSTEM CHECK
To ensure your computer is compatible for the live event, please perform a system check by clicking on the link http://livewebcast.net/test or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.

HARDWARE REQUIREMENTS
WINDOWS

  • 1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
  • Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
  • 512 MB of RAM (1 GB recommended)
  • Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)
MAC OS
  • 1.83 GHz Intel Core Duo or faster processor
  • 512 MB RAM (1 GB recommended)
  • Mac OS X 10.12, 10.13 and 10.14
  • Mozilla Firefox, Apple Safari, Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)
MOBILE
  • The Adobe Connect app for iOS and Android requires Adobe Connect Server version 8.2 or later
  • Some features may not be enabled in all Adobe Connect meetings if one is using an Adobe Connect Server older than version 9.4.2 (required for Custom pods)
  • Google Android 4.4 or later
  • Apple iOS: iOS 8.1.2 or later
SOFTWARE REQUIREMENTS
DSL/cable (wired connection recommended)

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/MOC CREDIT
There is no fee for this activity. To receive credit, participants must register, view the live CME/MOC activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.


Jointly provided by Boston University School of Medicine and Rockpointe



This program is supported by an educational grant from Merck & Co, Inc.

Rockpointe Privacy Policy